181 related articles for article (PubMed ID: 35282078)
1. Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
Li Z; Duan H; Guo J; Yang Y; Wang W; Hao M; Li W; Li P; Bin X; Lang J; Liu P; Chen C
Ann Transl Med; 2022 Jan; 10(2):122. PubMed ID: 35282078
[TBL] [Abstract][Full Text] [Related]
2. Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y; Li Z; Kang S; Yang Y; Ling B; Wang L; Yao J; Li P; Wang X; Gong S; Fan H; Kong Y; Cao Y; Lang J; Liu P; Chen C
BMC Cancer; 2023 May; 23(1):421. PubMed ID: 37161372
[TBL] [Abstract][Full Text] [Related]
3. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
Zhang Y; Wang C; Zhao Z; Cheng L; Xu S; Xie P; Xie L; Zhang S
Int J Gynaecol Obstet; 2024 Jun; 165(3):959-968. PubMed ID: 37950594
[TBL] [Abstract][Full Text] [Related]
5. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
[TBL] [Abstract][Full Text] [Related]
6. Hazard Ratio Analysis of Laparoscopic Radical Hysterectomy for IA1 With LVSI-IIA2 Cervical Cancer: Identifying the Possible Contraindications of Laparoscopic Surgery for Cervical Cancer.
Li P; Liu P; Yang Y; Wang L; Liu J; Bin X; Lang J; Chen C
Front Oncol; 2020; 10():1002. PubMed ID: 32733796
[No Abstract] [Full Text] [Related]
7. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y; Zhang G; Li Z; Chen B; Zhao H; Yang Y; Wang L; Yao J; Chen X; Huang Y; Lang J; Liu P; Chen C
Cancer Med; 2023 Oct; 12(19):19617-19632. PubMed ID: 37768092
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
10. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
[TBL] [Abstract][Full Text] [Related]
11. Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018).
Chen X; Liang W; Duan H; Wu M; Zhan X; Dai E; Lv Q; Xie Q; Liu R; Xu Y; Bin X; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():800049. PubMed ID: 35494051
[TBL] [Abstract][Full Text] [Related]
12. Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China.
Liu X; Wang J; Hu K; Zhang F; Meng Q; Wang W; Wang D; Zhou Z; Ren K
Cancer Manag Res; 2020; 12():1405-1410. PubMed ID: 32161492
[TBL] [Abstract][Full Text] [Related]
13. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
14. Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy.
Li Z; Yang Q; Guo J; Liang G; Duan H; Wang S; Hao M; Liang W; Li D; Zhan X; Xie Q; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():933755. PubMed ID: 35875125
[TBL] [Abstract][Full Text] [Related]
15. Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China.
He J; Li D; Shen P; Liang W; Kang S; Zhang Y; Zhao H; Liu M; Wang X; Lin Z; Bin X; Lang J; Liu P; Chen C
Int J Clin Oncol; 2022 Mar; 27(3):619-625. PubMed ID: 34837596
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 2018 FIGO cervical cancer staging system.
Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study.
Li P; Zhan X; Lv C; Lin Z; Yang Y; Wang W; Wang S; Hao M; Zhu B; Bin X; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():879569. PubMed ID: 35847917
[TBL] [Abstract][Full Text] [Related]
18. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
[TBL] [Abstract][Full Text] [Related]
19. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
